Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Erasca Inc
(NQ:
ERAS
)
2.590
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.590
Bid (Size)
2.500 (2)
Ask (Size)
2.670 (3)
Prev. Close
2.590
Today's Range
2.590 - 2.590
52wk Range
1.510 - 3.450
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ERAS Stock Earnings: Erasca Misses EPS for Q2 2024
August 12, 2024
ERAS stock results show that Erasca missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday
May 23, 2024
Via
Benzinga
Performance
YTD
+19.35%
+19.35%
1 Month
-5.47%
-5.47%
3 Month
+11.64%
+11.64%
6 Month
+20.47%
+20.47%
1 Year
+34.20%
+34.20%
More News
Read More
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
May 23, 2024
Via
Benzinga
DXC Technology Issues Weak Outlook, Joins Take-Two Interactive And Other Big Stocks Moving Lower In Friday's Pre-Market Session
May 17, 2024
Via
Benzinga
ERAS Stock Earnings: Erasca Misses EPS for Q1 2024
May 08, 2024
Via
InvestorPlace
ERAS Stock Earnings: Erasca Beats EPS for Q4 2023
March 27, 2024
Via
InvestorPlace
Why Shares of Erasca Are Jumping Tuesday
October 10, 2023
Via
The Motley Fool
Erasca Reports First Quarter 2024 Business Updates and Financial Results
May 08, 2024
From
Erasca, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 19, 2024
Via
Benzinga
Erasca Announces $45 Million Oversubscribed Private Placement Financing
March 27, 2024
From
Erasca, Inc.
Via
GlobeNewswire
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
March 27, 2024
From
Erasca, Inc.
Via
GlobeNewswire
Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials
February 14, 2024
From
Erasca, Inc.
Via
GlobeNewswire
Erasca to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 01, 2024
From
Erasca, Inc.
Via
GlobeNewswire
Erasca to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Erasca, Inc.
Via
GlobeNewswire
3 Penny Stocks You’ll Regret Not Buying Soon: December Edition
December 20, 2023
Via
InvestorPlace
RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying
December 11, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Erasca Granted FDA Fast Track Designation for Pan-RAF Inhibitor Naporafenib in Patients with Advanced NRAS-Mutated Melanoma
December 11, 2023
From
Erasca, Inc.
Via
GlobeNewswire
$1.7M Bet On Erasca? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
December 07, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 28, 2023
Via
Benzinga
Erasca Achieves Key Milestones for Naporafenib and ERAS-801 Programs and Extends Cash Runway
November 28, 2023
From
Erasca, Inc.
Via
GlobeNewswire
Erasca Reports Third Quarter 2023 Financial Results and Business Updates
November 09, 2023
From
Erasca, Inc.
Via
GlobeNewswire
Erasca to Present at Upcoming Investor Conferences in November
November 08, 2023
From
Erasca, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 03, 2023
Via
Benzinga
Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday
October 31, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023
October 11, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.